SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-082646
Filing Date
2021-06-17
Accepted
2021-06-17 16:38:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2120091d1_defa14a.htm DEFA14A 15162
  Complete submission text file 0001104659-21-082646.txt   16204
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26301 | Film No.: 211025225
SIC: 2834 Pharmaceutical Preparations